MENU
ATNM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Actinium Pharmaceuticals (ATNM) Ownership - Who owns Actinium Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
100 Park Avenue
Phone
+1 646 677-3870
Employees
49
Web
https://www.actiniumpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
51.47M
P/E Ratio
N/A
Total Cash
5.62M
Projected Growth
N/A
Total Debt
1.98M
Revenue
N/A
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
0.18
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
ATNM
Capitalization
51.5M
P/E Ratio
N/A
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
5.62M
Total Cash/Share
0.18
Total Debt
1.98M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
N/A
ROE
N/A
Book Value
43.9M
P/B Ratio
1.17
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
10.59
Current Revenue Per Employee
1653.06
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
64M
Shares Outstanding - Current
31.2M
Total Liabilities
44.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-67.520
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Park Avenue
Phone
+1 646 677-3870
Employees
49
Web
https://www.actiniumpharma.com